loadpatents
name:-0.006709098815918
name:-0.01190710067749
name:-0.00043082237243652
Preuschoff; Ulf Patent Filings

Preuschoff; Ulf

Patent Applications and Registrations

Patent applications and USPTO patent grants for Preuschoff; Ulf.The latest application filed is for "dual nk2/nk3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation".

Company Profile
0.10.7
  • Preuschoff; Ulf - Isernhagen N.B. DE
  • Preuschoff; Ulf - Lehrte/Ahlten DE
  • Preuschoff; Ulf - Isernhagen DE
  • Preuschoff; Ulf - Hannover DE
  • Preuschoff; Ulf - Uelzen DE
  • Preuschoff, Ulf - US
  • Preuschoff, Ulf - Lehrte DE
  • Preuschoff; Ulf - Uelzen/Oldenstadt DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds
Grant 7,767,692 - Jasserand , et al. August 3, 2
2010-08-03
Method of preparing pharmaceutical compositions
Grant 7,282,325 - Hebebrand , et al. October 16, 2
2007-10-16
Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation
App 20070219214 - Jasserand; Daniel ;   et al.
2007-09-20
Hydronopol derivatives as agonists on human ORL1 receptors
Grant 7,241,770 - Mentzel , et al. July 10, 2
2007-07-10
Method of treating or inhibiting obesity
Grant 7,238,470 - Hebebrand , et al. July 3, 2
2007-07-03
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
Grant 6,946,243 - Hebebrand , et al. September 20, 2
2005-09-20
Hydronopol derivatives as agonists on human ORL1 receptors
App 20050131004 - Mentzel, Matthias ;   et al.
2005-06-16
Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
Grant 6,900,322 - Reggelin , et al. May 31, 2
2005-05-31
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
App 20040167213 - Hebebrand, Johannes ;   et al.
2004-08-26
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
App 20040167214 - Hebebrand, Johannes ;   et al.
2004-08-26
1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds
App 20040152732 - Jasserand, Daniel ;   et al.
2004-08-05
1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
Grant 6,770,649 - Jasserand , et al. August 3, 2
2004-08-03
1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
App 20030125557 - Jasserand, Daniel ;   et al.
2003-07-03
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
App 20020022245 - Hebebrand, Johannes ;   et al.
2002-02-21
10, 13, 15-trioxatricyclo [9.2.1.1..sup.9.6 ]-pentadecan one derivatives, method for their production and pharmaceutical compositions containing them
Grant 5,912,235 - Hoeltje , et al. June 15, 1
1999-06-15
4,13-dioxabicyclo[8.2.1]tridecenone compounds and pharmaceutical compositions containing them
Grant 5,418,224 - Hoeltje , et al. May 23, 1
1995-05-23
6-oxoazepinoindole compounds, and pharmaceutical compositions containing them
Grant 5,272,143 - Benson , et al. December 21, 1
1993-12-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed